GLP-1 therapies, or glucagon-like peptide-1 analogs , represent a truly innovation in how we approach type 2 diabetes . These prescription drugs function to mimicking the body’s inherent GLP-1 process, https://bookmarkstime.com/story22448274/glp-1-a-significant-breakthrough-in-diabetes-management